key: cord-1021372-xke0mnwb authors: Rhodius‐Meester, Hanneke F.M.; Paajanen, Teemu; Koikkalainen, Juha; Mahdiani, Shadi; Bruun, Marie; Baroni, Marta; Lemstra, Afina W.; Scheltens, Philip; Herukka, Sanna‐Kaisa; Pikkarainen, Maria; Hall, Anette; Hänninen, Tuomo; Ngandu, Tiia; Kivipelto, Miia; van Gils, Mark; Hasselbalch, Steen Gregers; Mecocci, Patrizia; Remes, Anne; Soininen, Hilkka; van der Flier, Wiesje M.; Lötjönen, Jyrki title: cCOG: A web‐based cognitive test tool for detecting neurodegenerative disorders date: 2020-08-25 journal: Alzheimers Dement (Amst) DOI: 10.1002/dad2.12083 sha: 73fc451bb983df72f8c9218b47e267329ebc7255 doc_id: 1021372 cord_uid: xke0mnwb INTRODUCTION: Web‐based cognitive tests have potential for standardized screening in neurodegenerative disorders. We examined accuracy and consistency of cCOG, a computerized cognitive tool, in detecting mild cognitive impairment (MCI) and dementia. METHODS: Clinical data of 306 cognitively normal, 120 mild cognitive impairment (MCI), and 69 dementia subjects from three European cohorts were analyzed. Global cognitive score was defined from standard neuropsychological tests and compared to the corresponding estimated score from the cCOG tool containing seven subtasks. The consistency of cCOG was assessed comparing measurements administered in clinical settings and in the home environment. RESULTS: cCOG produced accuracies (receiver operating characteristic‐area under the curve [ROC‐AUC]) between 0.71 and 0.84 in detecting MCI and 0.86 and 0.94 in detecting dementia when administered at the clinic and at home. The accuracy was comparable to the results of standard neuropsychological tests (AUC 0.69–0.77 MCI/0.91–0.92 dementia). DISCUSSION: cCOG provides a promising tool for detecting MCI and dementia with potential for a cost‐effective approach including home‐based cognitive assessments. Despite the great progress in diagnostic biomarkers for Alzheimer's disease (AD) and other types of dementia, only 20% to 50% of dementia cases are recognized and documented. 1 This indicates a need for simple and efficient tools as well as clinical procedures for timely detection of neurodegenerative disorders. Although no cure for major neurodegenerative disorders such as AD is available, early diagnosis, combined with adequate management, can affect cognition, delay institutionalization, and lead to socioeconomic benefits. 2, 3 Early detection and treatment of patients with cognitive impairment is estimated to be cost effective even when taking the increased assessment costs into account. 4 In clinical practice, elderly persons with suspected cognitive impairment are typically first evaluated with simple cognitive tests, such as the Mini-Mental State Examination (MMSE), 5 Montreal Cognitive Assessment, 6 Clock Drawing Test 7 or Consortium to Establish a Registry for Alzheimer's Disease (CERAD) battery. 8 Further examinations with comprehensive neuropsychological assessments are ordered according to the clinical symptoms and cognitive screening results already obtained. Neuropsychological examinations are, however, time consuming and require a specialist psychologist. Web-based tests may increase the availability of testing (in the clinic, and perhaps even at home) and help to reduce costs at the same time. 9, 10 In addition, results can be more easily integrated into electronic patient data platforms. 11 Web-based cognitive tests have been found to be promising in measuring cognition in population level 12 and in detecting mild cognitive impairment (MCI) and dementia. 13, 14 However, test performance can vary depending on test devices. 12, 15, 16 Also retest reliability of self-administered cognitive tests and their correlation to the traditional neuropsychological tests varies. 12, 14, 17 Despite the clear benefits and potential of web-based tests, they are clearly underused in clinical settings. In this study, we present a web-based self-administrable cognitive test tool, cCOG, designed for early detection of neurodegenerative disorders. cCOG tasks were developed based on traditional cognitive tests to maintain the internal validity and to support clinicians to interpret the results. In validation, the correlation with standard neuropsychological tests (presenting the gold standard of cognition) was studied first. Then, the test tool accuracy to detect MCI and dementia was evaluated and compared to standard neuropsychological tests. Finally, the internal consistency of the cCOG was studied with a special interest in comparing measurements administered at clinical settings and in the home environment. Three study cohorts including cCOG measurements were used: 1) The PredictND (Predict Neurodegenerative Disorders) cohort (PredictND) included patients with MMSE ≥ 25 and contained data from 323 cognitively normal, MCI, and dementia patients from four European memory clinics. The data were acquired during 2015 to 2016. 18, 19 2) The VPH-DARE@IT (Virtual The participants in all the cohorts received a clinical work-up including medical history, physical assessment, traditional neuropsychological assessments, and laboratory tests. Subjects were diagnosed as cognitively normal when the cognitive complaints could not be confirmed by cognitive testing and criteria for MCI or dementia were not met. The Petersen criteria were used to define MCI. 24, 25 Patients were diagnosed with dementia according to the criteria for the specific underlying neurodegenerative disorder. 26-32 A global cognitive score composed of several standard neuropsychological tests was developed to serve as a gold standard for the overall status of cognition. This score was developed to optimally separate cognitively normal cases from cases with cognitive impairment. To construct a global cognitive score, we selected a subset of tests that was available in all the cohorts: MMSE 5 was selected as a measure for global cognition, learning and delayed recall scores of Rey Auditory Verbal Learning Task (RAVLT) 33 or CERAD word list memory task for episodic memory, 8 Trail Making Test A and B conditions (TMT-A, TMT-B) for mental processing speed and executive function, 34 categorical (animals) verbal fluency for language and executive function, 35 and digit span test (forward and backward) 36 for working memory/attention and executive functioning. To bridge differences between cohorts, Z-scores for RAVLT and CERAD were used. The independent Amsterdam Dementia Cohort was used for setting the parameters of the global cognitive score, which was defined as an index computed by feeding the abovementioned measures to the disease-state index (DSI) classifier. 37 DSI is a supervised learning method that processes heterogeneous patient data to derive a numeric index value between zero and one denoting the disease status of a patient. In this study, a global cognitive score value of zero means a high similarity to subjects with dementia (worse cognitive performance) while the value of one means a high similarity to cognitively normal subjects (better cognitive performance). Finally, a global cognitive score was computed for all subjects of the PredictND, VPHDARE, and FIN-GER cohorts. The supporting information appendix gives more details about the method. Computerized cognitive test tool (cCOG) and left) to which the user should react by pressing the arrow button as quickly as possible. In Task 2, the user should hit the arrow button on the right "→" whenever "R" is displayed. In Task 3, both "R" and "L" letters are displayed, and the user should hit the right arrow "→" for "R" and the left arrow "←" for "L." In Task 6 (Episodic memory test: Recall task), the user is asked to recall and type the words from Task 1. In Task 7 (Episodic memory test; Recognition task), the user is asked to recognize the word/picture combinations shown previously in Task 1. The user is shown altogether 24 word/picture images and asked to recognize whether the word was shown in Task 1. cCOG tasks were quantified as follows: The Spearman correlation coefficient was computed between the cog- Classification accuracy in diagnostics Figure 1 shows the distributions of MMSE, global cognitive score, and cCOG for different diagnostic groups in all three study cohorts. Table 3 presents classification performance in detecting MCI and dementia patients using MMSE, global cognitive score, and cCOG in PredictND. The results indicate that classification accuracy is comparable between global cognitive score and cCOG. Consistency of the cCOG results between clinic and home-based assessments was analyzed using the PredictND data. This study validated a self-administrable web-based cognitive test tool for the early detection of neurodegenerative disorders. The test was designed in such a way that tasks resemble standard tests were good when compared to previously developed web-based test batteries. 12, 16, 42, 43 Also cCOG memory subscore correlations with traditional memory tests were comparable to those reported recently among MCI and healthy elderly. 17 The consistency over time was studied using data from four time points, two measured at clinic and two at home. cCOG showed very strong correlation both in clinic (r = 0.82) and at home (r = 0.77). World Alzheimer Report. The benefits of early diagnosis and intervention Economic evaluation of treatment options in patients with Alzheimer's disease: a systematic review of cost-effectiveness analyses A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial An economic evaluation of early assessment for Alzheimer's disease in the United Kingdom Mini-mental state". A practical method for grading the cognitive state of patients for the clinician MoCA: a brief screening tool for mild cognitive impairment Clock-drawing: is it the ideal cognitive screening test? The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Status of computerized cognitive testing in aging: a systematic review Neuropsychological assessment: past and future Neuropsychological tests of the future: how do we get there from here? Performance of the CogState computerized battery in the Mayo Clinic study on aging Unsupervised online neuropsychological test performance for individuals with mild cognitive impairment and dementia: results from the Brain Health Registry Reliability and validity of the NeuroCognitive Performance Test, a web-based neuropsychological assessment Are we there yet? Exploring the impact of translating cognitive tests for dementia using mobile technology in an aging population Validation of the standardized touchscreen assessment of cognition with neurotypical adults A computerized, self-administered test of verbal episodic memory in elderly patients with mild cognitive impairment and healthy participants: a randomized, crossover, validation study Impact of a clinical decision support tool on prediction of progression in earlystage dementia: a prospective validation study Impact of a clinical decision support tool on dementia diagnostics in memory clinics: the PredictND validation study The association between distinct frontal brain volumes and behavioral symptoms in mild cognitive impairment, Alzheimer's disease, and frontotemporal dementia The Finnish geriatric intervention study to prevent cognitive impairment and disability (FIN-GER): study design and progress Optimizing patient care and research: the Amsterdam dementia cohort Amsterdam dementia cohort: performing research to optimize care Practice guideline update summary: mild cognitive impairment Mild cognitive impairment as a diagnostic entity Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia Vascular dementia: diagnostic criteria for research studies Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium Test performance and classification statistics for the Rey Auditory Verbal Learning Test in selected clinical samples Validity of the trail making test as an indicator of organic brain damage Normative data for the animal, profession and letter M naming verbal fluency tests for Dutch speaking participants and the effects of age, education, and sex A disease state fingerprint for evaluation of Alzheimer's disease Simple and choice reaction time and the use of advance information for motor preparation in Parkinson's disease Straightforward Statistics for the Behavioral Sciences A systematic review of the diagnostic accuracy of automated tests for cognitive impairment A comparison of the Cambridge Automated Neuropsychological Test Battery (CANTAB) with "traditional" neuropsychological testing instruments Reliability and validity of a self-administered tool for online neuropsychological testing: the Amsterdam cognition scan Initial validation of a web-based self-administered neuropsychological test battery for older adults and seniors Reliability of repeated cognitive assessment of dementia using a brief computerized battery Evidence of practice effect in CANTAB spatial working memory test in a cohort of patients with mild cognitive impairment Test-retest reliability analysis of the Cambridge Neuropsychological Automated Tests for the assessment of dementia in older people living in retirement homes At home cognitive testing (CANTAB battery) in healthy controls and cognitively impaired patients: a feasibility study CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI) How to cite this article: Rhodius-Meester HFM cCOG: A web-based cognitive test tool for detecting neurodegenerative disorders